| Bioengineering of therapeutic aerosols DA Edwards, C Dunbar Annual review of biomedical engineering 4 (1), 93-107, 2002 | 172 | 2002 |
| Pulmonary formulations: what remains to be done? JG Weers, J Bell, HK Chan, D Cipolla, C Dunbar, AJ Hickey, IJ Smith Journal of Aerosol Medicine and Pulmonary Drug Delivery 23 (S2), S-5-S-23, 2010 | 129 | 2010 |
| In vitro and in vivo dose delivery characteristics of large porous particles for inhalation C Dunbar, G Scheuch, K Sommerer, M DeLong, A Verma, R Batycky International journal of pharmaceutics 245 (1-2), 179-189, 2002 | 118 | 2002 |
| Pharmaceutical compositions of (r)-1-(2, 2-difluorobenzo [d][1, 3] dioxol-5-yl)-n-(1-(2, 3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl … RG Alargova, CA Dunbar, IN Kadiyala US Patent App. 13/214,419, 2012 | 114 | 2012 |
| An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques CA Dunbar, AP Watkins, JF Miller Journal of aerosol medicine 10 (4), 351-368, 1997 | 101 | 1997 |
| Analysis of cascade impactor mass distributions C Dunbar, J Mitchell Journal of aerosol medicine 18 (4), 439-451, 2005 | 90 | 2005 |
| Inhalation device D Edwards, M DeLong, C Dunbar, EE Penachio, K Stapleton, M Wolff US Patent 6,766,799, 2004 | 89 | 2004 |
| Evaluation of probability density functions to approximate particle size distributions of representative pharmaceutical aerosols CA Dunbar, AJ Hickey Journal of aerosol science 31 (7), 813-831, 2000 | 80 | 2000 |
| Inhalation device and method D Edwards, M DeLong, C Dunbar, EE Penachio, K Stapleton, M Wolff US Patent 7,146,978, 2006 | 72 | 2006 |
| Atomizat10n Mechanisms of the Pressurized Metered Dose Inhaler CA Dunbar Particulate science and technology 15 (3-4), 253-271, 1997 | 63 | 1997 |
| A new millennium for inhaler technology AJ Hickey, CA Dunbar Pharmaceutical technology 21 (6), 116-125, 1997 | 62 | 1997 |
| Reducing bounce effects in the Andersen cascade impactor C Dunbar, A Kataya, T Tiangbe International journal of pharmaceutics 301 (1-2), 25-32, 2005 | 60 | 2005 |
| Theoretical investigation of the spray from a pressurized metered-dose inhaler CA Dunbar, JF Miller Atomization and Sprays 7 (4), 1997 | 59 | 1997 |
| Pharmaceutical Compositions of (R)-1-(2, 2-Difluorobenzo [D][1, 3] dioxol-5-yl)-N-(1-(2, 3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl … RG Alargova, CA Dunbar, IN Kadiyala US Patent App. 14/656,043, 2015 | 55 | 2015 |
| Dose delivery characteristics of the AIR® pulmonary delivery system over a range of inspiratory flow rates M DeLong, J Wright, M Dawson, T Meyer, K Sommerer, C Dunbar Journal of aerosol medicine 18 (4), 452-459, 2005 | 48 | 2005 |
| Evaluation of atomizer performance in production of respirable spray-dried particles CA Dunbar, NM Concessio, AJ Hickey Pharmaceutical development and technology 3 (4), 433-441, 1998 | 34 | 1998 |
| A comparison of dry powder inhaler dose delivery characteristics using a power criterion CA Dunbar, B Morgan, M Van Oort, AJ Hickey PDA Journal of Pharmaceutical Science and Technology 54 (6), 478-484, 2000 | 30 | 2000 |
| Product quality research institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 3: final report on a statistical procedure for determining equivalence D Christopher, W Adams, A Amann, C Bertha, PR Byron, W Doub, ... AAPS PharmSciTech 8, 65-74, 2007 | 28 | 2007 |
| Pharmaceutical compositions of (R)-1-(2, 2-difluorobenzo [D][1, 3] dioxo1-5-y1)-N-(1-(2, 3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1 … RG Alargova, CA Dunbar, IN Kadiyala US Patent 10,058,546, 2018 | 27 | 2018 |
| An experimental and theoretical investigation of the spray issued from a pressurised metered-dose inhaler CA Dunbar University of Manchester, 1996 | 22 | 1996 |
